Coagulation activation in sickle cell trait: An exploratory study

British Journal of Haematology

Volumn 171, Issue 4, 2015, Pages 638-646

  Amin, Chirag ^a   Adam, Soheir ^a   Mooberry, Micah J ^a   Kutlar, Abdullah ^b   Kutlar, Ferdane ^b   Esserman, Denise ^c   Brittain, Julia E ^b   Ataga, Kenneth I ^a   Chang, Jen Yea ^a   Wolberg, Alisa S ^a   Key, Nigel S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c YALE UNIVERSITY   (United States)

Author keywords

Coagulation; Sickle; Thrombin; Tissue factor; Venous thrombosis

Indexed keywords

D DIMER; HEMOGLOBIN; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX; THROMBOPLASTIN; ANTITHROMBIN III; ANTITHROMBIN III-PROTEASE COMPLEX; AUTACOID; CYTOKINE; FIBRIN; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D; PEPTIDE HYDROLASE;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING; BLOOD SAMPLING; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PHLEBOTOMY; PRIORITY JOURNAL; SICKLE CELL TRAIT; THROMBOCYTE POOR PLASMA; BIOSYNTHESIS; BLOOD; CASE CONTROL STUDY; CHEMISTRY; COMPARATIVE STUDY; COMPLICATION; MEMBRANE MICROPARTICLE; MIDDLE AGED; PLASMA; SICKLE CELL ANEMIA; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

ADULT; AFRICAN AMERICANS; ANEMIA, SICKLE CELL; ANTITHROMBIN III; CASE-CONTROL STUDIES; CELL-DERIVED MICROPARTICLES; CYTOKINES; FEMALE; FIBRIN; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; PEPTIDE HYDROLASES; PLASMA; SICKLE CELL TRAIT; THROMBIN; THROMBOPHILIA; THROMBOPLASTIN; VENOUS THROMBOEMBOLISM;

EID: 84945441807     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.13641     Document Type: Article

References (52)

1. Ataga, K.I. & Key, N.S. (2007) Hypercoagulability in sickle cell disease: new approaches to an old problem. Hematology Am Soc Hematol Educ Program, 91-96.
2. Ataga, K.I., Cappellini, M.D. & Rachmilewitz, E.A. (2007) Beta-thalassaemia and sickle cell anaemia as paradigms of hypercoagulability. British Journal of Haematology, 139, 3-13.
3. Ataga, K.I., Moore, C.G., Hillery, C.A., Jones, S., Whinna, H.C., Strayhorn, D., Sohier, C., Hinderliter, A., Parise, L.V. & Orringer, E.P. (2008) Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension. Haematologica, 93, 20-26.
4. Austin, H., Key, N.S., Benson, J.M., Lally, C., Dowling, N.F., Whitsett, C. & Hooper, W.C. (2007) Sickle cell trait and the risk of venous thromboembolism among blacks. Blood, 110, 908-912.
5. Austin, H., Lally, C., Benson, J.M., Whitsett, C., Hooper, W.C. & Key, N.S. (2009) Hormonal contraception, sickle cell trait, and risk for venous thromboembolism among African American women. American Journal of Obstetrics and Gynecology, 200, e621-e623.
6. van Beers, E.J., Schaap, M.C., Berckmans, R.J., Nieuwland, R., Sturk, A., van Doormaal, F.F., Meijers, J.C. & Biemond, B.J.; CURAMA study group. (2009) Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. Haematologica, 94, 1513-1519.
7. Brittain, J.E., Derebail, V.K., Mooberry, M.J., Ataga, K.I., Kshirsagar, A.V. & Key, N.S. (2010) Increased red cell phosphatidylserine exposure correlates with enhanced thrombin generation in sickle trait patients with end stage renal disease. Blood, 116, Abstract 2665.
8. Bucknor, M.D., Goo, J.S. & Coppolino, M.L. (2014) The risk of potential thromboembolic, renal and cardiac complications of sickle cell trait. Hemoglobin, 38, 28-32.
9. Colella, M.P., De Paula, E.V., Conran, N., Machado-Neto, J.A., Annicchino-Bizzacchi, J.M., Costa, F.F., Saad, S.T. & Traina, F. (2012) Hydroxyurea is associated with reductions in hypercoagulability markers in sickle cell anemia. Journal of Thrombosis and Haemostasis, 10, 1967-1970.
10. Eichinger, S., Weltermann, A., Philipp, K., Hafner, E., Kaider, A., Kittl, E.M., Brenner, B., Mannhalter, C., Lechner, K. & Kyrle, P.A. (1999) Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden. Thrombosis and Haemostasis, 82, 1232-1236.
11. Engelmann, B. & Massberg, S. (2013) Thrombosis as an intravascular effector of innate immunity. Nature Reviews Immunology, 13, 34-45.
12. Folsom, A.R., Tang, W., Roetker, N.S., Kshirsagar, A.V., Derebail, V.K., Lutsey, P.L., Naik, R., Pankow, J.S., Grove, M.L., Basu, S., Key, N.S. & Cushman, M. (2015) Prospective study of sickle cell trait and venous thromboembolism incidence. Journal of Thrombosis and Haemostasis, 13, 2-9.
13. Geddings, J.E. & Mackman, N. (2013) Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients. Blood, 122, 1873-1880.
14. Gerotziafas, G.T., Van Dreden, P., Chaari, M., Galea, V., Khaterchi, A., Lionnet, F., Stankovic-Stojanovic, K., Blanc-Brude, O., Woodhams, B., Maier-Redelsperger, M., Girot, R., Hatmi, M. & Elalamy, I. (2012) The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles. Thrombosis and Haemostasis, 107, 1044-1052.
15. Goldsmith, J.C., Bonham, V.L., Joiner, C.H., Kato, G.J., Noonan, A.S. & Steinberg, M.H. (2012) Framing the research agenda for sickle cell trait: building on the current understanding of clinical events and their potential implications. American Journal of Hematology, 87, 340-346.
16. Gray, L.D., Hussey, M.A., Larson, B.M., Machlus, K.R., Campbell, R.A., Koch, G., Ezban, M., Hedner, U. & Wolberg, A.S. (2011) Recombinant factor VIIa analog NN1731 (V158D/E296V/M298Q-FVIIa) enhances fibrin formation, structure and stability in lipidated hemophilic plasma. Thrombosis Research, 128, 570-576.
17. 2 in venous valve pockets: its possible bearing on thrombogenesis. British Journal of Surgery, 68, 166-170.
18. Heller, P., Best, W.R., Nelson, R.B. & Becktel, J. (1979) Clinical implications of sickle-cell trait and glucose-6-phosphate dehydrogenase deficiency in hospitalized black male patients. New England Journal of Medicine, 300, 1001-1005.
19. Helley, D., Girot, R., Guillin, M.C. & Bezeaud, A. (1997) Sickle cell disease: relation between procoagulant activity of red blood cells from different phenotypes and in vivo blood coagulation activation. British Journal of Haematology, 99, 268-272.
20. Hemker, H.C., Al Dieri, R., De Smedt, E. & Beguin, S. (2006) Thrombin generation, a function test of the haemostatic-thrombotic system. Thrombosis and Haemostasis, 96, 553-561.
21. Hillery, C.A. & Panepinto, J.A. (2004) Pathophysiology of stroke in sickle cell disease. Microcirculation, 11, 195-208.
22. Hooper, W.C., Miller, C.H. & Key, N.S. (2010) Complications associated with carrier status among people with blood disorders: a commentary. American Journal of Preventive Medicine, 38, S456-S458.
23. Hope, M.J., Bally, M.B., Webb, G. & Cullis, P.R. (1985) Production of large unilamellar vesicles by a rapid extrusion procedure: characterization of size distribution, trapped volume and ability to maintain a membrane potential. Biochimica et Biophysica Acta, 812, 55-65.
24. Hoppe, C.C. (2014) Inflammatory mediators of endothelial injury in sickle cell disease. Hematology/oncology Clinics of North America, 28, 265-286.
25. Johnson, G.J., Leis, L.A. & Bach, R.R. (2009) Tissue factor activity of blood mononuclear cells is increased after total knee arthroplasty. Thrombosis and Haemostasis, 102, 728-734.
26. Key, N.S. & Derebail, V.K. (2010) Sickle-cell trait: novel clinical significance. Hematology Am Soc Hematol Educ Program, 2010, 418-422.
27. Key, N.S. & Mackman, N. (2010) Tissue factor and its measurement in whole blood, plasma, and microparticles. Seminars in Thrombosis and Hemostasis, 36, 865-875.
28. Key, N.S., Slungaard, A., Dandelet, L., Nelson, S.C., Moertel, C., Styles, L.A., Kuypers, F.A. & Bach, R.R. (1998) Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease. Blood, 91, 4216-4223.
29. Key, N.S., Connes, P. & Derebail, V.K. (2015) Negative health implications of sickle cell trait in developed countries: from the football field to the laboratory. British Journal of Haematology, 170, 5-14.
30. Lacroix, R., Dubois, C., Leroyer, A.S., Sabatier, F. & Dignat-George, F. (2013) Revisited role of microparticles in arterial and venous thrombosis. Journal of Thrombosis and Haemostasis, 11, 24-35.
31. Levi, M. & van der Poll, T. (2010) Inflammation and coagulation. Critical Care Medicine, 38, S26-S34.
32. Lim, M.Y., Ataga, K.I. & Key, N.S. (2013) Hemostatic abnormalities in sickle cell disease. Current Opinion in Hematology, 20, 472-477.
33. Luddington, R. & Baglin, T. (2004) Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition. Journal of Thrombosis and Haemostasis, 2, 1954-1959.
34. Lutsey, P.L., Cushman, M., Steffen, L.M., Green, D., Barr, R.G., Herrington, D., Ouyang, P. & Folsom, A.R. (2006) Plasma hemostatic factors and endothelial markers in four racial/ethnic groups: the MESA study. Journal of Thrombosis and Haemostasis, 4, 2629-2635.
35. Machlus, K.R., Colby, E.A., Wu, J.R., Koch, G.G., Key, N.S. & Wolberg, A.S. (2009) Effects of tissue factor, thrombomodulin and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram. Thrombosis and Haemostasis, 102, 936-944.
36. Naik, R.P., Streiff, M.B., Haywood, Jr, C., Segal, J.B. & Lanzkron, S. (2014) Venous thromboembolism incidence in the Cooperative Study of Sickle Cell Disease. Journal of Thrombosis and Haemostasis, 12, 2010-2016.
37. Noubouossie, D.C., Le, P.Q., Rozen, L., Ziereisen, F., Willems, D., Demulder, A. & Ferster, A. (2013) Thrombin generation in children with sickle cell disease: relationship with age, hemolysis, transcranial Doppler velocity, and hydroxyurea treatment. European Journal of Haematology, 91, 46-54.
38. Novelli, E.M., Huynh, C., Gladwin, M.T., Moore, C.G. & Ragni, M.V. (2012) Pulmonary embolism in sickle cell disease: a case-control study. Journal of Thrombosis and Haemostasis, 10, 760-766.
39. Owens, 3rd, A.P. & Mackman, N. (2011) Microparticles in hemostasis and thrombosis. Circulation Research, 108, 1284-1297.
40. Pakbaz, Z. & Wun, T. (2014) Role of the hemostatic system on sickle cell disease pathophysiology and potential therapeutics. Hematology/oncology Clinics of North America, 28, 355-374.
41. Piel, F.B., Patil, A.P., Howes, R.E., Nyangiri, O.A., Gething, P.W., Dewi, M., Temperley, W.H., Williams, T.N., Weatherall, D.J. & Hay, S.I. (2013) Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet, 381, 142-151.
42. Roberts, L.N., Patel, R.K., Chitongo, P., Bonner, L. & Arya, R. (2013) African-Caribbean ethnicity is associated with a hypercoagulable state as measured by thrombin generation. Blood Coagulation & Fibrinolysis, 24, 40-49.
43. Salvagno, G.L., Lippi, G., Montagnana, M., Poli, G., Giavarina, D., Manzato, F. & Guidi, G.C. (2008) Performance of the automated and rapid HemosIL D-Dimer HS on the ACL TOP analyzer. Blood Coagulation & Fibrinolysis, 19, 817-821.
44. Setty, B.N., Key, N.S., Rao, A.K., Gayen-Betal, S., Krishnan, S., Dampier, C.D. & Stuart, M.J. (2012) Tissue factor-positive monocytes in children with sickle cell disease: correlation with biomarkers of haemolysis. British Journal of Haematology, 157, 370-380.
45. Sevitt, S. (1974) Organization of valve pocket thrombi and the anomalies of double thrombi and valve cusp involvement. British Journal of Surgery, 61, 641-649.
46. Singhal, A., Doherty, J.F., Raynes, J.G., McAdam, K.P., Thomas, P.W., Serjeant, B.E. & Serjeant, G.R. (1993) Is there an acute-phase response in steady-state sickle cell disease? Lancet, 341, 651-653.
47. Sparkenbaugh, E. & Pawlinski, R. (2013) Interplay between coagulation and vascular inflammation in sickle cell disease. British Journal of Haematology, 162, 3-14.
48. Stein, P.D., Beemath, A., Meyers, F.A., Skaf, E. & Olson, R.E. (2006) Deep venous thrombosis and pulmonary embolism in hospitalized patients with sickle cell disease. American Journal of Medicine, 119(10):897.e7-11.
49. Tripette, J., Connes, P., Hedreville, M., Etienne-Julan, M., Marlin, L., Hue, O. & Hardy-Dessources, M.D. (2010) Patterns of exercise-related inflammatory response in sickle cell trait carriers. British Journal of Sports Medicine, 44, 232-237.
50. Tripodi, A., Cappellini, M.D., Chantarangkul, V., Padovan, L., Fasulo, M.R., Marcon, A. & Mannucci, P.M. (2009) Hypercoagulability in splenectomized thalassemic patients detected by whole-blood thromboelastometry, but not by thrombin generation in platelet-poor plasma. Haematologica, 94, 1520-1527.
51. Tsaras, G., Owusu-Ansah, A., Boateng, F.O. & Amoateng-Adjepong, Y. (2009) Complications associated with sickle cell trait: a brief narrative review. American Journal of Medicine, 122, 507-512.
52. Westerman, M.P., Green, D., Gilman-Sachs, A., Beaman, K., Freels, S., Boggio, L., Allen, S., Schlegel, R. & Williamson, P. (2002) Coagulation changes in individuals with sickle cell trait. American Journal of Hematology, 69, 89-94.